PROVIDER PROFILE · NPI 1013414507

Dylan Bellavance

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,722

Beneficiaries

—

Total drug cost

$229K

Distinct drugs

Brand share

17.2%

Top prescribed drugs

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$69

Payment records

By payment type

Food and Beverage$69

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (3)

Home health agency

Hospital

Hospital

CROSS-REFERENCE